Portfolio

We cherry-pick Israeli (or Israel-related) venture-backed bio-pharma companies across different development stages.

We’re actively looking for companies that meet the following criteria:

State-of-the-art scientific foundations backed by strong IP protection

Have already attracted investment from world-class investors

Indications inadequate or non-existent therapies

Leadership by industry veterans – executives to scientists

A rich pipeline to follow the lead indication